Par Drugs & Che.

PAR29 Apr 2024

Pharmaceuticals

₹

+6.15 (+2.32%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Par Drugs & Che.

Par Drugs & Che.

Pharmaceuticals

PAR29 Apr 2024

₹

+6.15 (+2.32%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date	Ratio
09-Nov-2021	D	Par Drugs And Chemicals Limited has informed the Exchange about Dividend Updates	22-Nov-2021
01-Jun-2020	D	Par Drugs And Chemicals Limited has informed the Exchange that Board of Directors at its meeting held on Jun 01, 2020, recommended Final Dividend of 1.25 per equity share.	10-Jul-2020
11-Nov-2019	D	Par Drugs And Chemicals Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on November 11, 2019 has declared an Interim dividend on equity share at the rate of 12.50% i.e. Rs. 1.25 per equity share of the face value of Rs. 10 each of Equity shareholders of the company.	22-Nov-2019
19-Apr-2021	B	Adjustment of Market Lot for security PARin SME PlatforM ar Drugs and Chemicals Limitedhas informed the Exchange that the Company has fixed Record Date as April 28 2021 for the purpose of issue of Bonus shares in the ratio of 1:1(OneEquity shares oF Rs.10/-each for every Onefully paid up Equity Share of Rs.10/-held by the shareholders) Symbol PAR Bonus issue ratio : 1:1 Ex-Date April 27, 2021 The adjusted market lot on account of bonus issue shall be 4000 The above changes shall be effective from April 27, 2021 Members are advised to load the updated security.gz/nnf_security.gz file in the trading application before trading on April 27, 2021. These files can be obtained from the directory common/NTNEAT on the Extranet server For and on behalf ofNational Stock Exchange of India Limited	28-Apr-2021	1:1
28-Feb-2024	BC	To consider other business matters Par Drugs And Chemicals Limited has informed the Exchange regarding Outcome of Board Meeting held on March 07, 2024. (As Per NSE Announcement Dated on: 07/03/	07-Mar-2024
06-Feb-2024	BC	To consider and approve the financial results for the period ended December 31, 2023 and other business matters PAR : 16-Feb-2024 : The Company has informed the Exchange that a Board meeting to be	16-Feb-2024
19-Oct-2023	BC	To consider and approve the financial results for the period ended September 30, 2023 and other business matters Par Drugs And Chemicals Limited has informed the Exchange regarding Board meeting	28-Oct-2023
17-Aug-2023	BC	Par Drugs And Chemicals Limited has informed the Exchange regarding Outcome of Board Meeting held on August 17, 2023. Par Drugs And Chemicals Limited has informed the Exchange regarding 'Outcome o	16-Sep-2023
17-Aug-2023	BC	Par Drugs And Chemicals Limited has informed the Exchange that Register of Members & Share Transfer Books of the Company will remain closed from 09-Sep-2023 to 16-Sep-2023 for the purpose of Meeting.	09-Sep-2023

No Rights has been declared by PAR

Book Closure

Record Date	Split Date	Purpose
07-Mar-2024	-	To consider other business matters Par Drugs And Chemicals Limited has informed the Exchange regarding Outcome of Board Meeting held on March 07, 2024. (As Per NSE Announcement Dated on: 07/03/
16-Feb-2024	01 Jan'1900	To consider and approve the financial results for the period ended December 31, 2023 and other business matters PAR : 16-Feb-2024 : The Company has informed the Exchange that a Board meeting to be
28-Oct-2023	-	To consider and approve the financial results for the period ended September 30, 2023 and other business matters Par Drugs And Chemicals Limited has informed the Exchange regarding Board meeting
16-Sep-2023	-	Par Drugs And Chemicals Limited has informed the Exchange regarding Outcome of Board Meeting held on August 17, 2023. Par Drugs And Chemicals Limited has informed the Exchange regarding 'Outcome o
09-Sep-2023	01 Jan'1900	Par Drugs And Chemicals Limited has informed the Exchange that Register of Members & Share Transfer Books of the Company will remain closed from 09-Sep-2023 to 16-Sep-2023 for the purpose of Meeting.

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Par Drugs & Chemicals Ltd ₹271.05(+6.15/2.32%)	271.05	+6.15	333.52	61.92	23.45	4.24
Lupin Ltd ₹1,637.45(+21.50/1.33%)	1,637.45	+21.50	74,626.80	131.02	36.21	3.87
Ipca Laboratories Ltd ₹1,334.00(-4.50/-0.34%)	1,334.00	-4.50	33,844.14	88.32	61.44	5.45
J B Chemicals & Pharmaceuticals Ltd ₹1,906.65(+41.60/2.23%)	1,906.65	+41.60	29,590.22	83.33	58.44	11.03
Sanofi India Ltd ₹8,277.50(+3.35/0.04%)	8,277.50	+3.35	19,063.08	52.52	32.30	18.78
IOL Chemicals & Pharmaceuticals Ltd ₹396.50(-3.00/-0.75%)	396.50	-3.00	2,327.67	-3.19	13.49	1.46

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	24.00	25.89	22.93	24.49	22.93	24.82
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	24.00	25.89	22.93	24.49	22.93	24.82
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.23	0.05	0.01	0.03	0.04	0.02
Total Income	24.23	25.94	22.95	24.52	22.97	24.83
Total Expenditure	18.77	18.52	18.80	19.11	19.70	18.91
PBIDT	5.46	7.41	4.14	5.41	3.27	5.92
Interest	0.02	0.03	0.02	0.03	0.03	0.03
PBDT	5.44	7.38	4.13	5.39	3.24	5.89
Depreciation	0.87	0.85	0.83	0.85	0.74	0.91
Tax	1.15	1.65	0.83	1.14	0.63	1.25
Deferred Tax	0.00	0.00	0.00	-0.05	0.00	0.00
Reported Profit After Tax	3.42	4.89	2.47	3.45	1.87	3.73
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	3.42	4.89	2.47	3.45	1.87	3.73

EPS (Unit Curr.)	2.78	3.97	2.01	2.80	1.52	3.03
EPS (Adj) (Unit Curr.)	2.78	3.97	2.01	2.80	1.52	3.03
Calculated EPS (Unit Curr.)	2.78	3.98	2.01	2.80	1.52	3.03
Calculated EPS (Adj) (Unit Curr.)	2.78	3.98	2.01	2.80	1.52	3.03
Calculated EPS (Ann.) (Unit Curr.)	11.12	15.90	8.02	11.21	6.07	12.11
Calculated EPS (Adj) (Ann.) (Unit Curr.)	11.12	15.90	8.02	11.21	6.07	12.11
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	12.30	12.30	12.30	12.30	12.30	12.30
Reserve & Surplus	69.72	66.29	61.40	58.93	55.46	53.59
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	22.75	28.62	18.05	22.09	14.26	23.85
PBDTM(%)	22.67	28.51	18.01	22.01	14.13	23.73
PATM(%)	14.25	18.89	10.77	14.09	8.16	15.03

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	12.30	12.30	6.15	6.15	4.48	8.45
Reserves Total	58.93	47.57	46.06	34.46	24.55	12.25
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	71.23	59.87	52.21	40.61	29.03	20.70
Secured Loans	0.00	0.00	4.52	0.61	11.58	13.50
Unsecured Loans	0.00	0.00	3.80	5.40	0.00	9.62
Total Debt	0.00	0.00	8.32	6.01	11.58	23.12
Total Liabilities	71.23	59.87	60.53	46.62	40.61	43.82
APPLICATION OF FUNDS :
Gross Block	67.57	60.02	52.54	57.34	56.71	56.36
Less : Accumulated Depreciation	29.12	25.91	22.63	22.94	20.37	17.33
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	38.45	34.11	29.91	34.40	36.34	39.03
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	0.25	0.25	4.52	0.74	0.00	0.00
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.01	0.01	0.01	0.06	0.06	0.06
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	5.38	4.71	3.00	2.92	4.29	4.07
Sundry Debtors	16.97	18.47	12.45	12.37	8.52	8.72
Cash and Bank	22.24	16.21	21.16	7.38	0.03	0.06
Loans and Advances	4.85	4.18	4.57	1.55	1.34	1.17
Total Current Assets	49.44	43.56	41.19	24.21	14.18	14.03
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	10.07	11.46	8.50	7.50	6.03	5.94
Provisions	3.92	3.40	3.55	1.95	0.87	0.67
Total Current Liabilities	13.99	14.86	12.05	9.45	6.91	6.61
Net Current Assets	35.45	28.71	29.14	14.77	7.27	7.42
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.07	0.12	0.14	0.13	0.11	0.29
Deferred Tax Liability	3.57	3.67	3.55	3.78	3.53	3.53
Net Deferred Tax	-3.50	-3.55	-3.41	-3.65	-3.42	-3.24
Total Assets	70.65	59.52	60.17	46.32	40.25	43.28
Contingent Liabilities	0.11	0.10	0.24	0.24	0.19	0.20

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	16.21	21.16	7.38	0.03	0.06
Net Cash from Operating Activities	13.38	7.62	12.09	7.69	2.10
Net Cash Used In Investing Activities	-7.34	-3.02	0.05	-1.46	-0.25
Net Cash Used In Financing Activities	0.00	-9.55	1.65	1.11	-1.88
Net Inc./Dec In Cash And Cash Equivalents	6.04	-4.96	13.78	7.35	-0.03
Cash And Cash Equivalents At End Of The Year	22.24	16.21	21.16	7.38	0.03

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

74.21%

FII Shareholding

0.07%

DII Shareholding

0.00%

Public Shareholding

25.73%

**Promoter pledged shareholding 74.21%

About Par Drugs & Chemicals Ltd

Par Drugs & Chemicals Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 333.52 crores. It has reported a sales of Rs. 24 crores and a net profit of Rs. 3.42 crores for the quarter ended December 2018. The company management includes FALGUN VALLABHBHAI SAVANI, FALGUN VALLABHBHAI SAVANI,JIGNESHBHAI VALLABHBHAI SAVANI,GHANSHAYAMBHAI BHAGVANBHAI SAVANI,Nayna Jignesh Savani,Krishna Mitulbhai Shah,Kajal Chintanbhai Vaghani,Pravin Manjibhai Bhayani,Bintal Bhaveshkumar Shah (Par Drugs & Chemicals Ltd) among others.

Chairman

FALGUN VALLABHBHAI SAVANI

Registered office

805 Dwarkesh Complex,RC Dutt Road Alkapuri,Vadodara,Gujarat,390007

FAX :

Background

Incorporation Year1999

Face Value₹10

Market Lot1

How to buy Par Drugs & Che. shares on nse?

To buy Par Drugs & Che. shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Par Drugs & Che. share price today?

The Par Drugs & Che. shares price on nse is Rs.271.05 today.

What is the market cap of Par Drugs & Che. shares on NSE ?

The company has a market capitalization of Rs.333.52Cr

What is the PE & PB ratio of Par Drugs & Che. shares ?

PE is 23.45 and PB is 4.24

What is the 52 Week High and Low of Par Drugs & Che. shares?

Par Drugs & Che. stock price high: Rs.325 Par Drugs & Che. stock price low: Rs.161.6